During the past decade, Arizona Eye Center conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 13 clinical trials were completed, i.e. on average, 72.2% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 12 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Arizona Eye Center" #1 sponsor was "Allergan" with 4 trials, followed by "Santen Inc." with 3 trials sponsored, "Shire" with 3 trials sponsored, "Aerie Pharmaceuticals" with 2 trials sponsored and "Kala Pharmaceuticals, Inc." with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

According to Clinical.Site data, the most researched conditions in "Arizona Eye Center" are "Ocular Hypertension" (4 trials), "Cataract" (2 trials), "Dry Eye Disease" (2 trials), "Dry Eye Syndromes" (2 trials) and "AMD" (1 trials). Many other conditions were trialed in "Arizona Eye Center" in a lesser frequency.

Most popular intervention types in "Arizona Eye Center" are "Drug" (20 trials), "Other" (4 trials), "Device" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Vehicle" (5 trials), "Placebo" (3 trials), "Bimatoprost SR" (2 trials), "DE-117 Ophthalmic Solution" (2 trials) and "Dexamethasone" (2 trials). Other intervention names were less common.

The vast majority of trials in "Arizona Eye Center" are 22 trials for "All" genders.

Currently, there are NaN active trials in "Arizona Eye Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 16 completed trials in Arizona Eye Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Arizona Eye Center, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".